Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00299793 · ClinicalTrials.gov registry record

Observational Study of Lamotrigine

A clinical trial, sponsored by Northwell Health.

Completed
Registry status
60
Enrollment target

NCT00299793: Completed study, sponsored by Northwell Health.

NCT00299793 is a clinical trial that has completed, run by Northwell Health. The registered enrollment target is 60 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00299793 has completed, sponsored by Northwell Health.

COMPLETED
Registry status
60 participants
Enrollment target

Study Summary

The purpose of this study is to assess efficacy, safety and tolerability of lamotrigine as used in a natural clinical setting, to examine the positive effects of lamotrigine, and the reasons why some patients choose to continue or discontinue lamotrigine.

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2001-10
Northwell Health

370 total trials

What the finished NCT00299793 record still lists

NCT00299793 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 60 participants, a relatively small participant target.

The record links to 0 conditions, and to 0 interventions.

NCT00299793 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00299793 about?

NCT00299793 is a clinical study titled "Observational Study of Lamotrigine". The purpose of this study is to assess efficacy, safety and tolerability of lamotrigine as used in a natural clinical setting, to examine the positive effects of lamotrigine, and the reasons why some patients choose to continue or discontinue lamotrigine.

What is the current status of trial NCT00299793?

This trial is currently completed. The enrollment target is 60 participants. The study started on 2001-10.

Who is sponsoring clinical trial NCT00299793?

This trial is sponsored by Northwell Health, which has 370 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00576069 · 60 participants

    Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma

  • NCT01297400 · 60 participants · Phase 2

    Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns

  • NCT01734122 · 60 participants

    Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor

  • NCT01804634 · 60 participants · Phase 2

    Reduced Intensity Haploidentical BMT for High Risk Solid Tumors

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00299793, the US trial registry maintained by the National Library of Medicine. NCT00299793 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.